Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
"Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil".
Jardim DL, Gonçalves E Silva A, Pompeo ASFL, Sarkis AS, Cardoso APG, Sasse AD, Fay AP, Soares A, Pompeo ACL, Carneiro A, Kann AG, Fogassa C, De Freitas CH Junior, Chade DC, Herchenhorn D, De Almeida DVP, Da Rosa DAR, Wiermann EG, Schutz FAB, Kater FR, De Moura F, Korkes F, Meyer F, De Oliveira FNG, Sabino F, Almeida GL, Avanço G, Guimaraes GC, Lemos GC, Carvalhal GF, Kim H, Morbeck IP, Campagnari JC, Rinck JA Junior, Da Ponte JRT, Da Trindade KM, Atem L, Borges L, Nogueira LM, Batista LTEA, Maia MC, Sadi MV, Rocha MAA, Luz MA, Smaletz O, Lages PSM, Matuda RMK, Reis RBD, Indio RF, Fernandes RC, Cavallero SR, Souza VC, Busato W Jr, Alfer W Junior, Maluf F. Jardim DL, et al. Among authors: fogassa c. Clin Genitourin Cancer. 2023 Apr;21(2):e58-e69. doi: 10.1016/j.clgc.2022.09.005. Epub 2022 Sep 10. Clin Genitourin Cancer. 2023. PMID: 36266221 Free article.
Evaluation of prognostic factors in patients undergoing first-line chemotherapy for advanced biliary tract cancer: a retrospective analysis from a South American cancer centre.
Felismino TC, Oliveira FMA, Fogassa CAZ, Santerini SN, de Jesus VHF, Riechelmann RSP, Coimbra FJF, Mello CAL. Felismino TC, et al. Among authors: fogassa caz. Ecancermedicalscience. 2022 Jan 17;16:1345. doi: 10.3332/ecancer.2022.1345. eCollection 2022. Ecancermedicalscience. 2022. PMID: 35242226 Free PMC article.
HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer.
de Moura Leite L, Cesca MG, Tavares MC, Santana DM, Saldanha EF, Guimarães PT, Sá DDS, Simões MFE, Viana RL, Rocha FG, Loose SK, Silva SF, Pirolli R, Fogassa CAZ, Mattos BRS, Campos FAB, Sanches SM, de Lima VCC, Pondé NF. de Moura Leite L, et al. Among authors: fogassa caz. Breast Cancer Res Treat. 2021 Nov;190(1):155-163. doi: 10.1007/s10549-021-06365-7. Epub 2021 Aug 18. Breast Cancer Res Treat. 2021. PMID: 34409551